1312

Kontafarma China Holdings Limited

HK Healthcare Drug Manufacturers - Specialty & Generic

Latest week
10 Jul 2026
Close
0.028000
Fair value
0.031788
Next-week expectancy
Negative 44.04%
Sharemaestro

1312 Chart Pack

Kontafarma China Holdings Limited

Exchange
HKG
Latest week
10 Jul 2026
Close
0.028000
Fair value
0.031788
Next-week expectancy
Negative 44.04%
Generated
17 Jul 2026 13:29
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Chart Summary

Over the latest 12 completed weeks ending 2026-07-10, 1312 was broadly unchanged, moving from 0.03 to 0.03. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is 0.02 and has improved across the 12-week window. Market Dynamics is -0.22 on the latest week. Next-week expectancy is negative at 44.03% based on similar historical setup states.

Key Points

Week Ending
10 Jul 2026
Latest Close
0.03
12-Week Change
0.00%
Trend Signal
Inactive
Next-Week Expectancy
Negative 44.03%
Signal Weeks
0 of 12
Vs Trend Line
Below
Vs Fair Value
Below
Relative Strength
0.02
Market Dynamics
-0.22

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
10 Jul 2026
Latest Close
0.03
12-Week Change
0.00%
Trend Signal
Inactive
Next-Week Expectancy
Negative 44.03%
Signal Weeks
0 of 12
Vs Trend Line
Below
Vs Fair Value
Below
Relative Strength
0.02
Market Dynamics
-0.22

Over the latest 12 completed weeks ending 2026-07-10, 1312 was broadly unchanged, moving from 0.03 to 0.03. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is 0.02 and has improved across the 12-week window. Market Dynamics is -0.22 on the latest week. Next-week expectancy is negative at 44.03% based on similar historical setup states.

Industry Peers

Hong Kong equities in Drug Manufacturers - Specialty & Generic

Stock Exchange Week Open High Low Close Change
1889 Sanai Health Industry Group Company Limited HKG 10 Jul 2026 0.15 0.21 0.13 0.20 27.92%
8329 Shenzhen Neptunus Interlong Bio-technique Company Limited HKG 10 Jul 2026 0.10 0.13 0.10 0.12 20.79%
0911 Qianhai Health Holdings Limited HKG 10 Jul 2026 0.64 0.92 0.63 0.72 12.50%
6998 Edding Genor Group Holdings Limited HKG 10 Jul 2026 1.83 1.98 1.71 1.97 7.65%
0897 Wai Yuen Tong Medicine Holdings Limited HKG 10 Jul 2026 0.27 0.32 0.27 0.29 7.41%
8049 Jilin Province Huinan Changlong Bio-pharmacy Company Limited HKG 10 Jul 2026 2.32 2.50 2.30 2.46 6.03%
3839 Chia Tai Enterprises International Limited HKG 10 Jul 2026 9.00 9.89 8.95 9.50 5.56%
2552 Hua Medicine (Shanghai) Ltd. HKG 10 Jul 2026 2.57 2.72 2.43 2.67 3.89%
2096 Simcere Pharmaceutical Group Limited HKG 10 Jul 2026 11.68 12.38 11.34 12.09 3.51%
1498 PuraPharm Corporation Limited HKG 10 Jul 2026 0.29 0.30 0.29 0.30 3.45%
1513 Livzon Pharmaceutical Group Inc. HKG 10 Jul 2026 24.88 26.84 24.88 25.70 3.30%
3737 Zhongzhi Pharmaceutical Holdings Limited HKG 10 Jul 2026 0.67 0.70 0.66 0.69 2.99%
0867 China Medical System Holdings Limited HKG 10 Jul 2026 11.57 12.43 11.42 11.90 2.85%
2633 Jacobson Pharma Corporation Limited HKG 10 Jul 2026 1.06 1.09 1.04 1.09 2.83%
0455 Tianda Pharmaceuticals Limited HKG 10 Jul 2026 0.09 0.10 0.09 0.09 2.22%
0719 Shandong Xinhua Pharmaceutical Company Limited HKG 10 Jul 2026 5.69 6.04 5.67 5.80 1.94%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.